Gerald E Quirk - Net Worth and Insider Trading
Gerald E Quirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald E Quirk owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , Eledon Pharmaceuticals Inc (ELDN) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Gerald E Quirk’s form 4 insider trades.
Insider Ownership Summary of Gerald E Quirk
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SYRS | Syros Pharmaceuticals Inc | 2016-09-26 | Chief Legal Officer |
ELDN | Eledon Pharmaceuticals Inc | 2015-05-26 | General Counsel & Executive VP |
INFIQ | Infinity Pharmaceuticals Inc | 2010-01-01 | VP,Cor. Affairs & Gnrl Counsel |
Gerald E Quirk Trading Performance
Gerald E Quirk Ownership Network
Ownership Network List of Gerald E Quirk
Ownership Network Relation of Gerald E Quirk
Gerald E Quirk Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Gerald E Quirk is the Chief Legal Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Gerald E Quirk made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Gerald E Quirk Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald E Quirk. You might contact Gerald E Quirk via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Cambridge Ma 02139.